SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
SEC Accession No. 0001354457-20-000244
Filing Date
2020-06-10
Accepted
2020-06-10 10:19:34
Documents
2
Effectiveness Date
2020-06-10

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 25-NSE  
1 primary_doc.xml 25-NSE 1092
2 form25.txt EX-99.25 93
  Complete submission text file 0001354457-20-000244.txt   2811
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Subject) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE | Act: 34 | File No.: 001-35619 | Film No.: 20953760
SIC: 2834 Pharmaceutical Preparations

Mailing Address Office of General Counsel 805 King Farm Blvd. ROCKVILLE MD 20850
Business Address One Liberty Plaza New York NY 10006 301-978-4144
The Nasdaq Stock Market LLC (Filed by) CIK: 0001354457 (see all company filings)

IRS No.: 521165937 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE